Xing Li
发表
Z. Yao,
G. Jiang,
P. Zhou,
2021,
Mucosal Immunology.
Xing Li,
Jie-Ming Dong,
Jinchao Liu,
2020,
Global challenges.
Q. Xiao,
M. Shi,
Jie Zhou,
2016,
Immunology.
Q. Xiao,
P. Zhou,
Jie Zhou,
2019,
Cell reports.
H. Yao,
Haiyu Zhou,
Hai Hu,
2021,
Journal of thoracic disease.
Xing Li,
Xiangyuan Wu,
L. Zou,
2019,
Cancer biotherapy & radiopharmaceuticals.
K. Deng,
P. Zhou,
Jie Zhou,
2020,
The Journal of Immunology.
Jie Zhou,
Xing Li,
A. Lei,
2017,
International immunopharmacology.
Ziqing Li,
Shuhong Wu,
Shuai Huang,
2017,
Molecular medicine reports.
E. Jensen,
A. Kossenkov,
V. Kagan,
2017,
Nature Medicine.
Dong-hao Wu,
Xing Li,
Xiangyuan Wu,
2020,
OncoTargets and therapy.
Xing Li,
Xiangyuan Wu,
Q. Lin,
2018,
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
Dong-hao Wu,
Xing Li,
Xiangyuan Wu,
2018,
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
Jun Huang,
Hongyan Xie,
Xing Li,
2021,
Frontiers in Immunology.
W. Zhou,
Shuai Huang,
Bowen Wu,
2018,
Oncology reports.
E. Jensen,
Q. Xiao,
Wei Zhou,
2019,
The Journal of clinical investigation.
P. Zhou,
Juan He,
Xing Li,
2021,
Mucosal Immunology.
Xing Li,
Xiangyuan Wu,
L. Zou,
2020,
FEBS open bio.
miR-30b regulates chondrogenic differentiation of mouse embryo-derived stem cells by targeting SOX9.
Shuai Huang,
Dongfeng Cai,
X. Zou,
2017,
Experimental and therapeutic medicine.